Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | SHR-A1921 |
Trade Name | |
Synonyms | SHR A1921|SHRA1921|SHRA 1921|SHR-1921 |
Drug Descriptions |
SHR-A1921 is an antibody-drug conjugate (ADC) comprising a monoclonal antibody targeting TROP2 conjugated to a DNA topoisomerase I inhibitor, which potentially induces tumor cell killing and and inhibits growth of tumors expressing TROP2 (Cancer Res (2023) 83 (8_Supplement): LB030, Cancer Res (2023) 83 (8_Supplement): CT181). |
DrugClasses | TROP2 Antibody 7 |
CAS Registry Number | NA |
NCIT ID | C193454 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SHR-A1921 | SHR-A1921 | 0 | 1 |